9 results
Search Results
2. Targeting -Acetyl-GD2 Ganglioside for Cancer Immunotherapy.
- Author
-
Fleurence, Julien, Fougeray, Sophie, Bahri, Meriem, Cochonneau, Denis, Clémenceau, Béatrice, Paris, François, Heczey, Andras, Birklé, Stéphane, Clémenceau, Béatrice, and Birklé, Stéphane
- Subjects
- *
CANCER immunotherapy , *GANGLIOSIDES , *TARGETED drug delivery , *T cells , *ANTIGEN receptors , *MONOCLONAL antibodies , *THERAPEUTICS , *LIPID metabolism , *THERAPEUTIC use of monoclonal antibodies , *TUMOR treatment , *CELL receptors , *CLINICAL trials , *IMMUNOGLOBULINS , *IMMUNOTHERAPY , *LIPIDS , *METABOLISM , *TUMOR antigens , *TUMORS - Abstract
Target selection is a key feature in cancer immunotherapy, a promising field in cancer research. In this respect, gangliosides, a broad family of structurally related glycolipids, were suggested as potential targets for cancer immunotherapy based on their higher abundance in tumors when compared with the matched normal tissues. GD2 is the first ganglioside proven to be an effective target antigen for cancer immunotherapy with the regulatory approval of dinutuximab, a chimeric anti-GD2 therapeutic antibody. Although the therapeutic efficacy of anti-GD2 monoclonal antibodies is well documented, neuropathic pain may limit its application. O-Acetyl-GD2, the O-acetylated-derivative of GD2, has recently received attention as novel antigen to target GD2-positive cancers. The present paper examines the role of O-acetyl-GD2 in tumor biology as well as the available preclinical data of anti-O-acetyl-GD2 monoclonal antibodies. A discussion on the relevance of O-acetyl-GD2 in chimeric antigen receptor T cell therapy development is also included. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy.
- Author
-
Dong, Zhaocheng, Liu, Zhiyuan, Dai, Haoran, Liu, Wenbin, Feng, Zhendong, Zhao, Qihan, Gao, Yu, Liu, Fei, Zhang, Na, Dong, Xuan, Zhou, Xiaoshan, Du, Jieli, Huang, Guangrui, Tian, Xuefei, and Liu, Baoli
- Subjects
REGULATORY B cells ,HUMORAL immunity ,KIDNEY diseases ,T cells ,HUMAN body ,KIDNEY glomerulus diseases ,CYTOKINES ,AUTOANTIBODIES ,IMMUNOGLOBULINS ,ANIMAL experimentation ,ARTHRITIS Impact Measurement Scales ,IMMUNOLOGY technique ,CELL communication ,PSYCHOLOGICAL tests ,DISEASE susceptibility ,IMMUNITY ,GLOMERULONEPHRITIS ,PSYCHOLOGICAL adaptation ,ANTIGENS - Abstract
Regulatory B cells (Breg) are widely regarded as immunomodulatory cells which play an immunosuppressive role. Breg inhibits pathological autoimmune response by secreting interleukin-10 (IL-10), transforming growth factor-β (TGF-β), and adenosine and through other ways to prevent T cells and other immune cells from expanding. Recent studies have shown that different inflammatory environments induce different types of Breg cells, and these different Breg cells have different functions. For example, Br1 cells can secrete IgG4 to block autoantigens. Idiopathic membranous nephropathy (IMN) is an autoimmune disease in which the humoral immune response is dominant and the cellular immune response is impaired. However, only a handful of studies have been done on the role of Bregs in this regard. In this review, we provide a brief overview of the types and functions of Breg found in human body, as well as the abnormal pathological and immunological phenomena in IMN, and propose the hypothesis that Breg is activated in IMN patients and the proportion of Br1 can be increased. Our review aims at highlighting the correlation between Breg and IMN and proposes potential mechanisms, which can provide a new direction for the discovery of the pathogenesis of IMN, thus providing a new strategy for the prevention and early treatment of IMN. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. Bisphenol A Exacerbates Allergic Inflammation in an Ovalbumin-Induced Mouse Model of Allergic Rhinitis.
- Author
-
Wang, Yunxiu, Cao, Zhiwei, Zhao, He, Ren, Yaoyao, Hao, Liying, and Gu, Zhaowei
- Subjects
BISPHENOL A ,ALLERGIC conjunctivitis ,ALLERGIC rhinitis ,RESPIRATORY mucosa ,TH2 cells ,PLASTICS ,ENDOCRINE disruptors ,ALBUMINS ,BENZENE ,BIOLOGICAL models ,CYTOKINES ,AIR pollution ,PHENOLS ,IMMUNOGLOBULINS ,RHINITIS ,MUCOUS membranes ,DISEASE susceptibility ,T cells ,INFLAMMATORY mediators ,TRANSCRIPTION factors ,ALLERGENS ,ANIMALS ,MICE - Abstract
Purpose: Bisphenol A (BPA) is found in many plastic products and is thus a common environmental endocrine disruptor. Plastic-related health problems, including allergic diseases, are attracting increasing attention. However, few experimental studies have explored the effect of BPA on allergic rhinitis (AR). We explore whether BPA was directly related to the allergic inflammation induced by ovalbumin (OVA) in AR mice.Methods: We first constructed OVA-induced mouse model, and after BPA administration, we evaluated nasal symptoms and measured the serum OVA-specific IgE levels by ELISA. Th2 and Treg-related cytokines of nasal mucosa were measured by cytometric bead array. Th2 and Treg-specific transcription factor levels were assayed by PCR. The proportions of CD3+CD4+IL-4+Th2 and CD4+Helios+Foxp3+ T cells (Tregs) in spleen tissue were determined by flow cytometry.Results: Compared to OVA-only-induced mice, BPA addition increased nasal symptoms and serum OVA-specific IgE levels. OVA and BPA coexposure significantly increased IL-4 and IL-13 protein levels compared to those after OVA exposure alone. BPA plus OVA tended to decrease the IL-10 protein levels compared to those after OVA alone. Coexposure to OVA and BPA significantly increased the GATA-3-encoding mRNA level, and decreased the levels of mRNAs encoding Foxp3 and Helios, compared to those after OVA exposure alone. BPA increased the Th2 cell proportion, and decreased that of Tregs, compared to the levels with OVA alone.Conclusion: BPA exerted negative effects by exacerbating AR allergic symptoms, increasing serum OVA-specific IgE levels, and compromising Th2 and Treg responses. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
5. DNA Vaccine Treatment in Dogs Experimentally Infected with .
- Author
-
Arce-Fonseca, Minerva, Carbajal-Hernández, Ana C., Lozano-Camacho, Mónica, Carrillo-Sánchez, Silvia del C., Roldán, Francisco-Javier, Aranda-Fraustro, Alberto, Rosales-Encina, José Luis, and Rodríguez-Morales, Olivia
- Subjects
DNA vaccines ,TRYPANOSOMA cruzi ,CHAGAS' disease ,BEAGLE (Dog breed) ,DOGS ,HEART physiology ,PROTOZOA ,INTERLEUKINS ,BIOLOGICAL models ,MYOCARDIUM ,VACCINES ,IMMUNOGLOBULINS ,CELL culture ,ANIMAL experimentation ,INTERLEUKIN-1 ,CELL physiology ,TRYPANOSOMIASIS ,ELECTROCARDIOGRAPHY ,T cells ,IMMUNOTHERAPY - Abstract
Chagas disease is a chronic and potentially lethal disorder caused by the parasite Trypanosoma cruzi, and an effective treatment has not been developed for chronic Chagas disease. The objective of this study was to determine the effectiveness of a therapeutic DNA vaccine containing T. cruzi genes in dogs with experimentally induced Chagas disease through clinical, pathological, and immunological analyses. Infection of Beagle dogs with the H8 T. cruzi strain was performed intraperitoneally with 3500 metacyclic trypomastigotes/kg body weight. Two weeks after infection, plasmid DNA immunotherapy was administered thrice at 15-day intervals. The clinical (physical and cabinet studies), immunological (antibody and cytokine profiles and lymphoproliferation), and macro- and microscopic pathological findings were described. A significant increase in IgG and cell proliferation was recorded after immunotherapy, and the highest stimulation index (3.02) was observed in dogs treated with the pBCSSP4 plasmid. The second treatment with both plasmids induced an increase in IL-1, and the third treatment with the pBCSSP4 plasmid induced an increase in IL-6. The pBCSP plasmid had a good Th1 response regulated by high levels of IFN-gamma and TNF-alpha, whereas the combination of the two plasmids did not have a synergistic effect. Electrocardiographic studies registered lower abnormalities and the lowest number of individuals with abnormalities in each group treated with the therapeutic vaccine. Echocardiograms showed that the pBCSSP4 plasmid immunotherapy preserved cardiac structure and function to a greater extent and prevented cardiomegaly. The two plasmids alone controlled the infection moderately by a reduction in the inflammatory infiltrates in heart tissue. The immunotherapy was able to reduce the magnitude of cardiac lesions and modulate the cellular immune response; the pBCSP treatment showed a clear Th1 response; and pBCSSP4 induced a balanced Th1/Th2 immune response that prevented severe cardiac involvement. The pBCSSP4 plasmid had a better effect on most of the parameters evaluated in this study; therefore, this plasmid can be considered an optional treatment against Chagas disease in naturally infected dogs. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.
- Author
-
Sautto, Giuseppe A., Diotti, Roberta A., Wisskirchen, Karin, and Kahle, Kristen M.
- Subjects
COMMUNICABLE disease diagnosis ,IMMUNE system ,IMMUNOTHERAPY ,COMMUNICABLE disease treatment ,ANIMALS ,CELLULAR immunity ,COMMUNICABLE diseases ,IMMUNOGLOBULINS ,T cells ,VACCINES ,ANTIBODY formation - Published
- 2017
- Full Text
- View/download PDF
7. The Role of TLR4 on B Cell Activation and Anti-2GPI Antibody Production in the Antiphospholipid Syndrome.
- Author
-
Cheng, Si, Wang, Haibo, and Zhou, Hong
- Subjects
- *
TOLL-like receptors , *B cells , *ANTIPHOSPHOLIPID syndrome , *GLUCOSE 6-phosphatase , *IMMUNOGLOBULINS , *PATIENTS , *ANTIPHOSPHOLIPID syndrome treatment , *ANTIGENS , *AUTOANTIBODIES , *CELL differentiation , *CELL receptors , *CELLULAR signal transduction , *DRUG therapy , *CYTOKINES , *GLYCOPROTEINS , *IMMUNITY , *IMMUNOLOGY technique , *IMMUNOTHERAPY , *T cells , *TUMOR necrosis factors , *ANTIBODY formation - Abstract
High titer of anti-β2-glycoprotein I antibodies (anti-β2GPI Ab) plays a pathogenic role in antiphospholipid syndrome (APS). Numerous studies have focused on the pathological mechanism in APS; however, little attention is paid to the immune mechanism of production of anti-β2GPI antibodies in APS. Our previous study demonstrated that Toll-like receptor 4 (TLR4) plays a vital role in the maturation of bone marrow-derived dendritic cells (BMDCs) from the mice immunized with human β2-glycoprotein I (β2GPI). TLR4 is required for the activation of B cells and the production of autoantibody in mice treated with β2GPI. However, TLR4 provides a third signal for B cell activation and then promotes B cells better receiving signals from both B cell antigen receptor (BCR) and CD40, thus promoting B cell activation, surface molecules expression, anti-β2GPI Ab production, and cytokines secretion and making B cell functioning like an antigen presenting cell (APC). At the same time, TLR4 also promotes B cells producing antibodies by upregulating the expression of B-cell activating factor (BAFF). In this paper, we aim to review the functions of TLR4 in B cell immune response and antibody production in autoimmune disease APS and try to find a new way for the prevention and treatment of APS. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
8. Clinical Relevance of HLA Antibodies in Kidney Transplantation: Recent Data from the Heidelberg Transplant Center and the Collaborative Transplant Study.
- Author
-
Süsal, Caner, Fichtner, Alexander, Tönshoff, Burkhard, Mehrabi, Arianeb, Zeier, Martin, Morath, Christian, Süsal, Caner, and Tönshoff, Burkhard
- Subjects
KIDNEY transplantation ,IMMUNOGLOBULINS ,HLA histocompatibility antigens ,T cells ,ALGORITHMS ,ENZYME-linked immunosorbent assay ,GRAFT rejection ,GRAFT versus host reaction ,HISTOCOMPATIBILITY testing ,IMMUNIZATION ,IMMUNOLOGICAL adjuvants ,ORGAN donors ,HLA-B27 antigen - Abstract
Herein, we summarize our recent findings from the international Collaborative Transplant Study (CTS) and Heidelberg Transplant Center regarding the role of HLA antibodies in kidney transplantation and their application into the clinical routine. Based on the antibody findings from the CTS serum study, an algorithm was developed in 2006 for the transplantation of high-risk sensitized patients at the Heidelberg Transplant Center which includes seven different pre- and posttransplant measures. Using this algorithm, the number of transplantations could be increased in high-risk presensitized patients and the previously existing impact of antibodies on graft survival could greatly be diminished but not totally eliminated. More recent findings led to the hypothesis that T cell help from a preactivated immune system supports the harmful effects of pretransplant donor-specific HLA antibodies that otherwise disappear in many cases after transplantation without any consequence. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
9. B-CD8+ T Cell Interactions in the Anti-Idiotypic Response against a Self-Antibody.
- Author
-
Martínez, Darel, Pupo, Amaury, Cabrera, Lianet, Raymond, Judith, Holodick, Nichol E., Hernández, Ana María, Martínez, Darel, and Hernández, Ana María
- Subjects
GERM cells ,LABORATORY mice ,GANGLIOSIDES ,B cells ,T cells ,ANIMAL experimentation ,ANTIGENS ,AUTOANTIBODIES ,CELL communication ,IMMUNITY ,IMMUNIZATION ,IMMUNOGLOBULINS ,IMMUNOLOGICAL tolerance ,IMMUNOLOGY technique ,INTERFERONS ,INTERLEUKINS ,MICE ,MONOCLONAL antibodies - Abstract
P3 is a murine, germline, IgM mAb that recognizes N-glycolylated gangliosides and other self-antigens. This antibody is able to induce an anti-idiotypic IgG response and B-T idiotypic cascade, even in the absence of any adjuvant or carrier protein. P3 mAb immunization induces the expression of activation markers in a significant percentage of B-1a cells in vivo. Interestingly, transfer of both B-1a and B-2 to BALB/Xid mice was required to recover anti-P3 IgG response in this model. In fact, P3 mAb activated B-2 cells, in vitro, inducing secretion of IFN-γ and IL-4, although this activation was not detected ex vivo. Interestingly, naïve CD8+ T cells increased the expression of activation markers and IFN-γ secretion in the presence of B-1a cells isolated from P3 mAb-immunized mice, even without in vitro restimulation. In contrast, B-2 cells were able to stimulate CD8+ T cells only if P3 was added in vitro. Using bioinformatics, a MHC class I-binding peptide from P3 VH region was identified. P3 mAb was able to induce a specific CTL response in vivo against cells presenting this peptide. Both humoral and CTL anti-idiotypic responses could be mechanisms to protect against the self-reactive antibody, contributing to keeping the tolerance to self-antigens. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.